Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
- Resource Type
- Article
- Authors
- de Botton, Stéphane ; Cluzeau, Thomas; Vigil, Carlos; Cook, Rachel J.; Rousselot, Philippe; Rizzieri, David A.; Liesveld, Jane L.; Fenaux, Pierre; Braun, Thorsten; Banos, Anne; Jurcic, Joseph G.; Sekeres, Mikkael A.; Savona, Michael R.; Roboz, Gail J.; Bixby, Dale; Madigan, Kate; Volkert, Angela; Stephens, Kristin; Kang-Fortner, Qing; Baker, Kristen; Paul, Sofia; McKeown, Michael; Carulli, John; Eaton, Matthew; Hodgson, Graeme; Fiore, Christopher; Kelly, Michael J.; Roth, David A.; Stein, Eytan M.
- Source
- In Blood Advances 9 May 2023 7(9):1858-1870
- Subject
- Clinical Trials and Observations
Myeloid Neoplasia
- Language
- ISSN
- 2473-9529